Treatment of acute stroke with dextran 40

Completed

Phase N/A Results

Summary of Purpose

To determine the effect of intravenous dextran 40 in the treatment of acute cerebral ischemia and infarction due to thromboembolism.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 September 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Institute of Neurological Diseases and Stroke, Michigan Heart Association, Detroit General Hospital Research Corporation.

Trial Design

Randomized, controlled trial of 100 patients.

Contacts

Not available